Biosurgery Market size Global Gathering and Future Outlook 2020 to 2027
Biosurgery products are used in numerous surgical procedures
to minimize intra- and post-operative complications. The increasing geriatric
population, a growing number of surgical procedures, rising occurrences of
trauma and sports-related injuries are the major factors driving the growth of
the global biosurgery market.
Additionally, increasing R&D spending and aggressive
strategies adopted by the top players, such as new product launches, are
contributing to the growth of the biosurgery
market. For instance, in March 2015, Kuros Biosurgery announced the grant
of a US patent for its synthetic hydrogel technology which is a combination of
bioactive and biomaterial products such as sealants and orthobiologics.The high
costs associated with surgeries, stringent regulatory environment for product
approval, and increasing popularity of minimally invasive surgeries are likely
to hinder market growth during the forecast period.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6246
Key Players
Some of the key players in the global biosurgery market are
Baxter International, Inc., B. Braun
Melsungen AG, C.R. Bard, Johnson & Johnson, Medtronic, PLC., MAQUET Holding
B.V. & Co. Kg. (Getinge Group), Cohera Medical Inc., Integra Lifesciences
Holdings Corporation, Commonwealth Serum Laboratories (CSL), Hemostasis, LLC,
Sanofi, Pfizer Inc., Stryker Corporation, Cryolife, Inc., and Kuros Biosciences
Ltd.
Segmentation
The global biosurgery market has been segmented on the basis
of product, source, and application.
On the basis of product, the market has been classified as
bone graft substitutes, hemostatic agents, soft-tissue attachments, surgical
sealants and adhesives, adhesion barriers, and staple-line reinforcement
agents. The bone-graft substitutes segment has been further divided into
demineralized bone matrix, synthetic bone grafts, bone morphogenetic proteins,
and other bone-graft substitutes. The hemostatic agents segment has been
further divided into thrombin-based hemostatic agents, oxidized regenerated
cellulose-based hemostatic agents, and combination hemostatic agents. The
soft-tissue attachments segment has been classified as synthetic meshes and
biological meshes. The surgical sealants and adhesives segment has been divided
into natural and synthetic sealants and adhesives. The natural sealants
sub-segment has been segmented into fibrin sealants, collagen-based sealants,
gelatin-based sealants, albumin-based sealants, and other natural sealants. The
synthetic sealants segment has been divided into peg hydrogels,
cyanoacrylate-based sealants and adhesives, urethane-based sealants and
adhesives, and others. Furthermore, the adhesion barriers segment has been
sub-segmented into synthetic and natural adhesion barriers. The synthetic
adhesion barriers segment includes hyaluronic acid-based, peg-based, and ther
synthetic barriers. The natural adhesion barriers segment includes collagen-
and fibrin-based adhesion barriers.
The market, by source, has been segmented into biological
and natural products. On basis of application, the market has been divided into
neurological surgery, general surgery, cardiovascular surgery, orthopedic
surgery, thoracic surgery, gynecology surgery, reconstructive surgery, and
urology surgery.
Regional Analysis
The market in the Americas is expected to dominate the
global biosurgery market during the forecast period owing to the increasing
prevalence of chronic diseases along with the growing geriatric population,
rising occurrences of injuries, and well-established healthcare sector in the
region. The European market is expected to be the second-largest due to
government funding and support of the healthcare sector, coupled with
increasing research and development. Moreover, the market in Asia-Pacific is
anticipated to be the fastest-growing during the forecast period owing to
technological development, an increasing number of advanced surgeries in
emerging economies, and favorable government initiatives for healthcare
facilities. The market in the Middle East & Africa is likely to account for
the smallest share of the global biosurgery market. The market growth in this
region can be attributed to increasing healthcare expenditure and low
manufacturing costs of pharmaceuticals.
Browse Detailed TOC
with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/biosurgery-market-6246
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Comments
Post a Comment